Document is current
Any future updates will be listed below
-
Authors
Peeters, Ken
Van Leemputte, Frederik
Fischer, Baptiste https://orcid.org/0000-0001-9620-921X
Bonini, Beatriz M.
Quezada, Hector https://orcid.org/0000-0003-2663-4696
Tsytlonok, Maksym
Haesen, Dorien
Vanthienen, Ward
Bernardes, Nuno https://orcid.org/0000-0002-4495-6608
Gonzalez-Blas, Carmen Bravo https://orcid.org/0000-0003-0973-9410
Janssens, Veerle https://orcid.org/0000-0002-6772-8448
Tompa, Peter
Versées, Wim
Thevelein, Johan M. https://orcid.org/0000-0002-2626-0180
- License Information
-
More Information
Article History
Received: 7 July 2016
Accepted: 14 August 2017
First Online: 13 October 2017
Competing interests
: The authors declare possible competing interests. VIB/LRD has submitted a patent application on the use of the Fru1,6bisP interaction with Sos1 for the development of anticancer drugs (‘Activation of Ras by a fructose-1,6-bisphosphate/guanine nucleotide exchange protein complex.’ 26 July 2013. EP 13178157.7. K.P. and J.M.T.). The remaining authors declare no competing financial interests.
